Irinotecan Hydrochloride
These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996
afcdde49-ec0c-4c56-a1af-2917185b1a08
HUMAN PRESCRIPTION DRUG LABEL
Mar 10, 2021
Qilu Pharmaceutical Co., Ltd.
DUNS: 653878256
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Irinotecan Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Irinotecan Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Irinotecan Hydrochloride
Product Details
FDA regulatory identification and product classification information